RESUMEN
The combination of multiple observational probes has long been advocated as a powerful technique to constrain cosmological parameters, in particular dark energy. The Dark Energy Survey has measured 207 spectroscopically confirmed type Ia supernova light curves, the baryon acoustic oscillation feature, weak gravitational lensing, and galaxy clustering. Here we present combined results from these probes, deriving constraints on the equation of state, w, of dark energy and its energy density in the Universe. Independently of other experiments, such as those that measure the cosmic microwave background, the probes from this single photometric survey rule out a Universe with no dark energy, finding w=-0.80_{-0.11}^{+0.09}. The geometry is shown to be consistent with a spatially flat Universe, and we obtain a constraint on the baryon density of Ω_{b}=0.069_{-0.012}^{+0.009} that is independent of early Universe measurements. These results demonstrate the potential power of large multiprobe photometric surveys and pave the way for order of magnitude advances in our constraints on properties of dark energy and cosmology over the next decade.
RESUMEN
Auto-processing of the non-structural polypeptide 3ABC of foot and mouth disease virus (FMDV) expressed in Escherichia coli-BL21-DE3 was prevented by mutating either four glutamic acid residues at the 3A/3B1, 3B1/2, 3B2/3 and 3B3/3C junctions (3ABCtet) or a single cysteine residue at position 383 within the 3C domain (3ABCm). Independent expression of 3ABC and 3ABCtet genes induced expression of chaperone DnaK and degradation of ribosomal S1 protein in E. coli. They also induced cleavage of nucleosomal histone H3 when transiently expressed in BHK21 cells. 3ABCtet, 3ABCm, 3AB and 3A proteins concentrated in the perinuclear region suggesting that peptide sequences within the 3A domain specify intracellular targeting of 3ABC in BHK-21 cells. We propose that 3ABC molecules localized in the nuclear periphery are a source of protease 3C activity and are responsible for histone H3 processing during FMDV infections.
Asunto(s)
Cisteína Endopeptidasas/metabolismo , Virus de la Fiebre Aftosa/patogenicidad , Histonas/metabolismo , Péptidos/metabolismo , Proteínas no Estructurales Virales/metabolismo , Proteínas Virales/metabolismo , Proteasas Virales 3C , Animales , Línea Celular , Cricetinae , Cisteína Endopeptidasas/genética , Escherichia coli/enzimología , Escherichia coli/genética , Virus de la Fiebre Aftosa/enzimología , Virus de la Fiebre Aftosa/genética , Proteínas no Estructurales Virales/genética , Proteínas Virales/genéticaRESUMEN
The spread of the human immunodeficiency virus type 1 (HIV-1) is by now virtually worldwide. An understanding of the genetic, biological, and immunological differences among isolates collected in different geographic locales is crucial for the development of globally effective vaccines. Here we report the genetic characteristics of 21 HIV-1 isolates from Brazil. The isolates were initially characterized using a heteroduplex mobility assay. The majority (17 of 21) were related to North American/European reference isolates of genetic subtype B. Four isolates belonged to a more recently identified genotype, termed subtype F. The subtype F sequences from Brazil are distinguishable in both gag and env from five other genetic subtypes of HIV-1 currently recognized. Like many locales, Brazil harbors more than one HIV-1 subtype.
PIP: The spread of the human immunodeficiency virus type 1 (HIV-1) is by now virtually worldwide. An understanding of the genetic, biological, and immunological differences among isolates collected in different geographic locales is crucial for the development of globally effective vaccines. The genetic characteristics of HIV-1 isolates from whole blood samples of 21 HIV-1-seropositive Brazilian patients collected during 1989 and 1990 are reported. Virus was isolated by cocultivation of patient peripheral blood mononuclear cells (PBMCs) with phytohemagglutinin (PHA)-stimulated donor PBMCs. The isolates were initially characterized using a heteroduplex mobility assay, which estimates the DNA sequence homology of a selected genomic region from different HIV-1 isolated from the migration of heteroduplexes in polyacrylamide gels. Five distinct HIV-1 envelope subtypes were identified, and a sixth subtype, termed F, was identified using isolates from Brazil and Romania. One Brazilian isolate was identified as subtype B by the more rapid relative migration of heteroduplexes. The majority (17 of 21) were related to North American/European reference isolates of genetic subtype B, whereas 4 isolates belonged to subtype F, a more recently identified genotype. The gag and env genes of several Brazilian isolates belonging to subtypes B and F were cloned and sequenced to allow a detailed analysis of their phylogenic relationships. This further established the existence of two distinct and well-separated genetic subtypes among Brazilian HIV-1 isolates. The subtype F sequences from Brazil are distinguishable in both gag and env from 5 other genetic subtypes of HIV-1 currently recognized. Like many locales, Brazil harbors more than one HIV-1 subtype.
Asunto(s)
Infecciones por VIH/microbiología , VIH-1/genética , VIH-1/aislamiento & purificación , Vacunas contra el SIDA/aislamiento & purificación , Secuencia de Aminoácidos , Brasil , Productos del Gen env/genética , Productos del Gen gag/genética , Genes env , Genes gag , Proteína gp120 de Envoltorio del VIH/genética , VIH-1/clasificación , Humanos , Datos de Secuencia Molecular , Ácidos Nucleicos Heterodúplex/genética , Fragmentos de Péptidos/genética , Filogenia , Homología de Secuencia de Aminoácido , Especificidad de la EspecieRESUMEN
A review of the history of 'vaccine therapy' for infectious diseases is presented. The concept originated when Auzias-Turenne introduced 'syphilitic vaccination' or 'syphilization' as a treatment for syphilis in Paris in the mid-1800s; his clinical studies probably influenced Pasteur's successful rabies postexposure vaccine trials. Robert Koch in Berlin in the 1890s observed that inoculation of tuberculin into patients with tuberculosis induced an inflammatory response in affected tissues, and advocated 'tuberculin therapy'. Sir Almroth Wright in London in the early 20th century devised methods to measure changes in serum 'opsonizing' activity in response to therapeutic inoculations with microbe-derived vaccines. Since the advent of antibiotics, active specific immunization with microbe-derived antigens (vaccine therapy) has been largely forgotten as a strategy for treatment of infectious diseases. Advances in antigen production and in molecular immunology now permit new tactics to probe, analyse and selectively alter in vivo human immune responses to infectious microbes. Our recent demonstration that vaccine therapy can boost natural immunity to HIV in infected patients should rekindle interest in this approach.
Asunto(s)
Vacunas contra el SIDA/uso terapéutico , Infecciones por VIH/terapia , Inmunoterapia Activa/historia , Infecciones/terapia , Adyuvantes Inmunológicos/uso terapéutico , Antibacterianos/uso terapéutico , Antígenos/uso terapéutico , Ensayos Clínicos como Asunto , Europa (Continente) , Predicción , Historia del Siglo XIX , Historia del Siglo XX , Humanos , Inmunidad Activa , Medicina en la Literatura , Estados Unidos , Vacunación/historia , VenezuelaRESUMEN
Renal and related retroperitoneal abscesses cause significant morbidity and mortality and almost always require drainage. The authors report 18 cases of percutaneous drainage of renal and related retroperitoneal abscesses, all of which were successfully managed. In 11 of these cases (61%), percutaneous drainage constituted the only treatment required. In the remaining seven (39%), the patients' clinical status improved after percutaneous drainage, and they were able to undergo subsequent elective nephrectomy with fewer complications. These results are comparable to those achieved with percutaneous abdominal abscess drainage and justify the use of percutaneous drainage for renal and related retroperitoneal abscesses as the therapeutic procedure of choice.
Asunto(s)
Absceso/terapia , Enfermedades Renales/terapia , Espacio Retroperitoneal , Absceso/diagnóstico por imagen , Adulto , Anciano , Drenaje/métodos , Femenino , Humanos , Enfermedades Renales/diagnóstico por imagen , Masculino , Persona de Mediana Edad , Punciones/métodos , Radiografía , Espacio Retroperitoneal/diagnóstico por imagenRESUMEN
Dengue-2 virus strains from different locations were compared by T1-RNAse-resistant oligonucleotide fingerprinting and antigen signature analysis. The latter technique involved construction of radioimmunoassays using monoclonal antibodies that recognize nine distinct dengue-2 type-specific and flavivirus cross-reactive epitopes over a range of antigen concentrations. A statistical method was used to align unknown dengue antigen concentrations in different strain preparations, allowing comparison of binding profiles. Twenty-six dengue-2 virus strains were separated into five distinct groups (topotypes) on the basis of unique RNA fingerprints. Two of these were represented by New Guinea C, the prototype virus isolated in 1944, and a Philippine strain; others were segregated on the basis of greater than or equal to 80% shared oligonucleotides into similarity groups representing Burma/Thailand (8 strains), Puerto Rico (12 strains), and Jamaica (4 strains). Signature analysis of the prototype and four geographic topotype strains revealed striking antigenic differences. In contrast, a high degree of antigenic similarity was found among strains from the same geographic region. Variation between antigenically distinct strains occurred at both type-specific and group-reactive epitopes, but the widest differences appeared at group-reactive determinants. Signature analysis provides a more rapid and simpler means than RNA fingerprinting of monitoring changes or new introductions of dengue virus populations in a geographic region.
Asunto(s)
Antígenos Virales/análisis , Virus del Dengue/clasificación , Anticuerpos Monoclonales , Anticuerpos Antivirales , Antígenos Virales/inmunología , Reacciones Cruzadas , Virus del Dengue/genética , Virus del Dengue/inmunología , Epítopos , Jamaica , Mianmar , Nueva Guinea , Oligorribonucleótidos/análisis , Filipinas , Puerto Rico , ARN Viral/análisis , TailandiaRESUMEN
We studied the persistence of antibody to Venezuelan equine encephalomyelitis (VEE) virus subtypes in sera of 20 volunteers inoculated seven or nine years previously with attenuated TC-83 VEE virus vaccine. Serological patterns were compared with those of 10 other persons from whom samples of serum were obtained 28 days after vaccination with TC-83 virus. Vaccines had no other known exposure to a group A arbovirus. Titers of neutralizing antibody of greater than or equal to 1:10 were measured against the homologous TC-83 strain of virus in all long- and short-term vaccinees. In both groups of vaccinees the percentage of antibody-positive persons and their geometric mean titers of antibody to the epizootic subtypes I-A, I-B, and I-C were higher than titers to the enzootic subtypes I-D, I-E, II, III, and IV. However, proportionally fewer long-term vaccinees than short-term vaccinees had detectable neutralizing antibody reactive with enzootic strains. These results reveal long-lasting circulation of neutralizing antibody to TC-83 virus and closely related epizootic variants in 95%-100% of vaccinees. The relatively lower rate of antibody conversion and the loss of antibody to more antigenically remote enzootic subtypes of VEE virus suggest that vaccinees may be less well protected against infection by these strains.